Pre/Post-Conference Workshops
Thursday, 18 April 2013
MDMA-Assisted Psychotherapy Michael Mithoefer MD & Annie Mithoefer BSN
Summary available soon….
Neuroscience of Psychedelics
Dave Nichols, Ph.D. and Franz Vollenweider, M.D.
Workshop leaders will present the latest advances in scientific understanding of how psychedelics affect the brain, in terms that are accurate yet accessible. Topics will include: DMT and its role in the brain, new views on the receptor interactions of psychedelic agents, mechanisms of psychedelic-induced visuals, what makes MDMA different from most other psychedelics, and up-to-date information on the potential harms and benefits of these fascinating compounds.
Psychedelic Harm Reduction
Workshop Leaders to be announced soon.
This year millions of people will use psychedelics outside of supervised contexts, many of them for the first time. Many psychedelic users are unprepared to tend to a psychedelic-induced crisis if one were to arise. Difficult psychedelic experiences can be among the most frightening and disturbing experiences someone could have, but also potentially among the most valuable. Difficult psychedelic experiences can be the result of external factors, such as a chaotic environment or traumatic events, or the result of painful or troubling emotions that arise during the experience. By working with these emotions, rather than trying to "talk someone down," together the counselor (or "sitter") and the psychedelic user can make a difficult psychedelic experience an opportunity for personal growth. This workshop will explore the issues related to serving people in need, and responding to criticisms that such services encourage illegal use.
Beyond Therapy: Further Reaches of Psychedelic Experience
James Fadiman Ph.D. & Tom Roberts Ph.D.
Summary available soon….
Monday, 22 April 2013
Ayahuasca Perspectives
Beatriz Caiuby Labate, Chris Kilham, Kat Harrison, and Luís Fernando Tófoli, MD, Phd
Summary available soon….
Medical Marijuana
Donald Abrams, M.D., Clint Warner and others
Prominent experts will share the lessons they have learned about marijuana research methodology (such as dosing, self-titration, placebo doses, and outcome measures), discuss the differing effects of the two primary cannabinoids THC and CBD, examine the forces impeding government approval of medical marijuana research, explore the history of the medical marijuana movement in California from 1996 to the present, and discuss future possibilities for research. The implications of new data on the use of cannabis as a substitute for alcohol, illicit, and prescription drugs for the clinical application of medical marijuana will also be discussed.
Visionary Art with Andrew Jones
Summary available soon….
Special three-day Holotropic Breathwork workshop with Stan Grof
Sunday, 21 April 8pm – 10:00 pm
Monday, 22 April, 9am – 6 pm
Tuesday, 23 April, 9am – 12 noon
Summary available soon…
